Improved Lung Cancer Screening Could Lead to Earlier Detection

A recent research project commissioned for the Lung Cancer Alliance and several other interested organizations uses actuarial techniques to calculate the mortality difference between people who are diagnosed with early-stage lung cancer and those who are not diagnosed until lung cancer has reached its later, fatal stages. Milliman Insight recently sat down to discuss the implications of this paper with the authors, actuaries Bruce Pyenson, Sara Goldberg, and Dale Hagstrom, and cancer researcher Dr. James Mulshine, as well as with Laurie Fenton and Sheila Ross of the Lung Cancer Alliance. This interview puts the new research in a broader context—as part of the larger effort to reduce the mortality associated with a disease that kills more than 160,000 people every year.

http://insight.milliman.com/article.php?cntid=7224&utm_source=home&utm_m...